Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20112
20121
20141
20151
20171
20203
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Recruiting4
Completed3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Transgene2
AIO-Studien-gGmbH1
AbbVie1
BioNTech SE1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung14
Lung Neoplasms6
Neoplasms2
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1
Neoplasm Metastasis1
Recurrence1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.